Sign inJoin waitlistJoin the waitlist

DR

Damon Reed

Chief, Pediatric Sarcoma Service · New York Presbyterian Hospital

Credentials: · · · ·

History

Pediatric Sarcoma Service Division · New York Presbyterian Hospital
Present
New York Presbyterian Hospital
Present
Pediatric Sarcoma Division · New York Presbyterian Hospital
Present

Pediatrics
Harvard Medical School
2006–2007
St. Jude Children's Hospital
2005–2006
Pediatrics
Boston Children's Hospital
2002–2005
Case Western Reserve University School of Medicine
1998–2002

Research

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
The Lancet Oncology · 2017 · 1,203 citations
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre,…
The Lancet Oncology · 2017 · 258 citations
Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2018 · 257 citations

Katherine Janeway
25 papers
Richard Gorlick
18 papers
Steven DuBois
17 papers
AB
Andrew Brohl
16 papers
Odion Binitie
16 papers
WT
William Tap
16 papers
Marilyn Bui
15 papers
LM
Leo Mascarenhas
12 papers
MI
Michael Isakoff
12 papers
Brian Crompton
11 papers
ES
Emily Slotkin
11 papers
PG
Patrick Grohar
11 papers

Clinical trials

A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2026–2028
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
Principal investigator · Recruiting · Phase 2
National Cancer Institute (NCI)
2021–2027
Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies
Principal investigator · Completed · Phase 1
H. Lee Moffitt Cancer Center and Research Institute
2013–2016
Metformin in Children With Relapsed or Refractory Solid Tumors
Principal investigator · Completed · Phase 1
H. Lee Moffitt Cancer Center and Research Institute
2012–2020